BlackRock’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
236,641
-6,101
-3% -$26.3K ﹤0.01% 4174
2025
Q1
$908K Sell
242,742
-8,516
-3% -$31.9K ﹤0.01% 4177
2024
Q4
$2.55M Buy
251,258
+8,699
+4% +$88.2K ﹤0.01% 3917
2024
Q3
$3.02M Sell
242,559
-35,427
-13% -$441K ﹤0.01% 3823
2024
Q2
$3.62M Sell
277,986
-351,859
-56% -$4.58M ﹤0.01% 3748
2024
Q1
$14.3M Sell
629,845
-41,600
-6% -$942K ﹤0.01% 3117
2023
Q4
$8.71M Sell
671,445
-67,657
-9% -$878K ﹤0.01% 3397
2023
Q3
$14.9M Sell
739,102
-30,050
-4% -$604K ﹤0.01% 3055
2023
Q2
$20.7M Buy
769,152
+164,339
+27% +$4.41M ﹤0.01% 2964
2023
Q1
$35.3M Buy
604,813
+37,597
+7% +$2.19M ﹤0.01% 2626
2022
Q4
$28.9M Buy
567,216
+39,686
+8% +$2.02M ﹤0.01% 2782
2022
Q3
$43.2M Sell
527,530
-13,993
-3% -$1.15M ﹤0.01% 2524
2022
Q2
$36.6M Buy
541,523
+13,015
+2% +$880K ﹤0.01% 2664
2022
Q1
$58.4M Sell
528,508
-66,039
-11% -$7.3M ﹤0.01% 2458
2021
Q4
$57.3M Buy
594,547
+8,526
+1% +$822K ﹤0.01% 2536
2021
Q3
$51.2M Buy
586,021
+604
+0.1% +$52.7K ﹤0.01% 2618
2021
Q2
$90.6M Buy
585,417
+68,767
+13% +$10.6M ﹤0.01% 2294
2021
Q1
$81.5M Buy
516,650
+18,310
+4% +$2.89M ﹤0.01% 2281
2020
Q4
$116M Buy
498,340
+20,354
+4% +$4.73M ﹤0.01% 1977
2020
Q3
$105M Buy
477,986
+52,075
+12% +$11.4M ﹤0.01% 1832
2020
Q2
$121M Buy
425,911
+70,844
+20% +$20.1M ﹤0.01% 1713
2020
Q1
$102M Buy
355,067
+37,139
+12% +$10.7M 0.01% 1619
2019
Q4
$91.4M Buy
317,928
+4,759
+2% +$1.37M ﹤0.01% 2013
2019
Q3
$45.2M Buy
313,169
+11,402
+4% +$1.65M ﹤0.01% 2337
2019
Q2
$27.1M Buy
301,767
+23,180
+8% +$2.08M ﹤0.01% 2652
2019
Q1
$24.4M Sell
278,587
-5,274
-2% -$462K ﹤0.01% 2634
2018
Q4
$39.9M Sell
283,861
-174
-0.1% -$24.5K ﹤0.01% 2360
2018
Q3
$72.6M Buy
284,035
+13,659
+5% +$3.49M ﹤0.01% 2163
2018
Q2
$68.9M Buy
270,376
+86,505
+47% +$22M ﹤0.01% 2157
2018
Q1
$37M Buy
183,871
+7,928
+5% +$1.6M ﹤0.01% 2431
2017
Q4
$25.3M Sell
175,943
-26,915
-13% -$3.88M ﹤0.01% 2644
2017
Q3
$33.4M Buy
202,858
+5,528
+3% +$910K ﹤0.01% 2496
2017
Q2
$26.8M Buy
197,330
+30,183
+18% +$4.1M ﹤0.01% 2607
2017
Q1
$32.2M Buy
167,147
+166,870
+60,242% +$32.1M ﹤0.01% 2464
2016
Q4
$39K Sell
277
-16
-5% -$2.25K ﹤0.01% 2985
2016
Q3
$43K Sell
293
-140
-32% -$20.5K ﹤0.01% 2971
2016
Q2
$44K Buy
433
+337
+351% +$34.2K ﹤0.01% 2957
2016
Q1
$13K Sell
96
-73
-43% -$9.89K ﹤0.01% 2985
2015
Q4
$34K Buy
169
+39
+30% +$7.85K ﹤0.01% 2237
2015
Q3
$21K Buy
130
+89
+217% +$14.4K ﹤0.01% 2325
2015
Q2
$17K Buy
41
+18
+78% +$7.46K ﹤0.01% 2428
2015
Q1
$10K Sell
23
-5,534
-100% -$2.41M ﹤0.01% 2700
2014
Q4
$3.12M Sell
5,557
-1,287
-19% -$723K ﹤0.01% 943
2014
Q3
$3.59M Sell
6,844
-377
-5% -$198K 0.01% 898
2014
Q2
$5.04M Buy
7,221
+1,931
+37% +$1.35M 0.01% 817
2014
Q1
$2.45M Buy
5,290
+5,117
+2,958% +$2.37M ﹤0.01% 1003
2013
Q4
$60K Buy
+173
New +$60K ﹤0.01% 1837